Correlation between cognitive functions and nitric oxide levels in patients with dementia

Clinical EEG and Neuroscience

Volumn 42, Issue 3, 2011, Pages 190-194

  Sachdeva, Richa ^a   Babbar, Rashmi ^a   Puri, Vinod ^b   Agarwal, Sarita ^a   Krishana, Bal ^a  

^a MAULANA AZAD MEDICAL COLLEGE   (India)

^b G B PANT HOSPITAL   (India)

Author keywords

Cognition; Dementia; Event related potentials; Nitric oxide; P300

Indexed keywords

NITRIC OXIDE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CASE CONTROL STUDY; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; CLINICAL DEMENTIA RATING SCALE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; EVENT RELATED POTENTIAL; FEMALE; HUMAN; MALE; MINI MENTAL STATE EXAMINATION; NITRIC OXIDE BLOOD LEVEL; PRIORITY JOURNAL;

EID: 80051920133     PISSN: 15500594     EISSN: None     Source Type: Journal    
DOI: 10.1177/155005941104200309     Document Type: Article

References (45)

1. Panagariya A, Sharma AK, Udainiya DK. An etiological study of dementia in a tertiary care centre of North West India. Neurosci Today 2004; 8(2): 84-87.
2. Mann DMA, Neary D, Testa H. Introduction. In: Color Atlas and Text of Adult Dementias. England: Mosby-Wolfe; 1994: 9.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (DSM IV) 4th ed. Washington: The Association; 1994.
4. World Health Organization. The ICD-10 classification of mental and behavioural disorders. Diagnostic criteria for research. Geneva: World Health Organization, 1993.
5. Govoni S, Bolis CL, Trabucchi M. Classification and diagnosis of dementia. In: Dementia-Biological Bases and Clinical Approach to Treatment. Italy: Springer; 1999: 51-76.
6. Aminoff MJ. Event-related potentials. In: Electrodiagnosis in Clinical Neurology. 5th ed. Elsevier Science; 2005: 569-585.
7. Olichney JM, Hillert DG. Clinical applications of cognitive event-related potentials in Alzheimer's disease. Phys Med Rehabil Clin N Am 2004; 15: 205-233. (Pubitemid 38210040)
8. Katzman R, Terry RD, Bick EL .Alzheimer's Disease. Senile Dementia and Related Disorders. New York: Raven Press; 1978.
9. Alexander MP, Geschwind N. Dementia in the elderly. In: Albert ML (ed). Clinical Neurology of Aging. New York: Oxford University Press; 1984: 254-276.
10. Goodin DS, Squires KC, Henderson B, Starr A. Age related variation in evoked potentials to auditory stimuli in normal human subjects. Electroencephalogr Clin Neurophysiol 1978;44:447.
11. Tandon OP, Kumar S. P3 event related cerebral evoked potential in chronic pain patients. Ind J Physiol and Pharmacol 1990; 37(1): 51-55.
12. Milstien S, Sakai N, Brew BJ, Krieger C, Vickers JH, Saito K, et al. Cerebrospinal fluid nitrite/nitrate levels in neurological diseases. J Neurochem 1994; 63(3): 1178-1180. (Pubitemid 24266637)
13. Wei G, Dawson VL, Zweier JL. Role of neuronal and endothelid nitric oxide synthase in nitric oxide generation in the brain following cerebral ischemia. Biochimicaet Biophysica Acta 1999;1455:23-24.
14. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 2006; 147(suppl 1) 1: S193-201.
15. Boje KM, Arora PK. Microglial-produced nitric oxide and reactive nitrogen oxides mediate neuronal cell death. Brain Res 1992; 587: 250-256.
16. Chao CC, Hu S, Molitor TW, Shaskan EG, Peterson PK. Activated microglia mediate neuronal cell injury via a nitric oxide mechanism. J Immunol 1992; 149(8): 2736-2741.
17. Moro MA, Darley-Usmar VM, Goodwin DA, Read NG, Pino RZ, Feelisch M, et al. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 1994; 91: 6702-6706. (Pubitemid 24200730)
18. Rogers J, Luber-Narod J, Styren Sd, Civin WH. Expression of immune system-associated antigens by cells of the human central nervous system: relationship to the pathology of Alzheimer's disease. Neurobiol Aging 1988; 9(4): 339-349. (Pubitemid 19262065)
19. McGeer PL, Itagaki S, Boves BE, McGeer EG. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology 1988; 38(8): 1285-1291.
20. Navarro JA, Molina JA, Jimenez- Jimenez FJ, Benito-Leon J, Orti-Pareja M, Gasalla T, et al. Cerebrospinal fluid nitrate levels in patients with Alzheimer's disease. Acta Neurol Scand 1996; 94: 411-414. (Pubitemid 27026425)
21. Folstein MF, Folstein SE, McHugh PR. Mini-Mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiat Res 1975;12: 189-198.
22. Hughes CP, Berg L, Danziger W, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982; 140: 566-572. (Pubitemid 12124384)
23. Nuwer MR, Lehmann D, Silva FLD, Matsuoka S, Sutherling W. IFCN guidelines for topographic and frequency analysis of EEGs and EPs. Report of an IFCN Committee. Electroencephalogr Clin Neurophysiol 1994; 91: 1-5. (Pubitemid 24227365)
24. Kuiper MA, Visser JJ, Bergmans PL, Scheltens P, Wolters EC. Decreased cerebrospinal fluid nitrate levels in Parkinson's disease, Alzheimer's disease and multiple system atrophy patients. J Neurol Sci 1994; 121: 46-49. (Pubitemid 24025245)
25. Cortas NK, Wakid NW. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin Chem 1990; 36(8): 1440-1443.
26. Godfrey M, Majid DSA: Renal handling of circulating nitrates in anesthetized dogs. Am J Physiol. Renal Physiology 1998; 275(1): F68-F73.
27. Tarpey MM, Fridovich I. Methods of detection of vascular reactive species: nitric oxide, super oxide, hydrogen peroxide, and peroxy nitrate. Circ Res 2001; 89: 244-236.
28. Vaney N, Chouhan S, Bhatia MS, Tondon OP. Event related potentials in dementia: role of vitamine E. Indian J Physiol Pharmacol 2002; 46(1): 61-68. (Pubitemid 34086919)
29. Pfefferbaum A, Ford JM, Kraemer HC. Clinical Utility of long-latency 'cognitive' event-related potentials(P3):the cons. Electroencephalogr Clin Neurophysiol 1990; 76: 6-12.
30. Callaway E, Tueting P, Koslow S. The endogenous components of the ERP: event related brain potentials in man. In: Cognitive Psychophysiology. New York: Academic Press; 1987: 349-411.
31. Bakan E, Taysi S, Polat MF, Dalga S, Umudum Z, Bakan N, et al. Nitric oxide levels and lipid peroxidation in plasma of patients with gastric cancer. Jpn J Clin Oncol 2002; 32(5): 162-166. (Pubitemid 41289003)
32. Goodin DS, Aminoff MJ. Electrophysiological differences between subtypes of dementia. Brain 1986; 109: 1103-1113.
33. Polich J, Ehlers CL, Otis S, Mandell AJ, Bloom FE. P300 latency reflects the degree of cognitive decline in dementing illness. Electroencephalogr Clin Neurophysiol 1986; 63(2): 138-144. (Pubitemid 16154681)
34. Goodin DS, Squires KC, Starr A. A long latency event-related components of the auditory evoked potential in dementia. Brain 1978; 191: 635-648. (Pubitemid 9051161)
35. Brown WS, Marsh JT, LaRue A. Event related potentials in psychiatry: differentiating depression and dementia in the elderly. Bull Los Angeles Neurol Soc1982; 47: 91-107.
36. Hansch EC, Syndulko K, Cohen S, Golber Z, Potvin A, Tourtellotte W. Cognition in Parkinson's disease: an event related potential perspective. Ann Neurol 1982; 11: 599-607. (Pubitemid 12116421)
37. Squires KC, Chippendale TJ, Wrege KS, Goodin DS, Starr A. Electrophysiological assessment of mental function in aging and dementia. In: Poon LW (ed). Aging in 1980's: Selected Contemporary Issues in the Psychology of Aging. Washington, DC: American Psychological Association; 1980: 125-134.
38. Leppler JG, Greenberg HJ. The P3 potential and its clinical usefulness in the objective classification of dementia. Cortex 1984; 20: 427-433. (Pubitemid 14031973)
39. Gordon E, Kraiuhin C, Harris A, Meares R, Howson A. The differential diagnosis of dementia using P3 latency. Biol Psychiat 1986; 33; 1215-1218.
40. Pfefferbaum A, Wenegrat BG, Ford JM, Roth WT, Kopell BS. Clinical application of the P3 component of event-related potentials. II. Dementia, depression, schjzophrenia. Electroencephalogr Clin Neurophysiol 1984; 59(2): 104-124.
41. Bannister SR. Dementia and higher cerebral function. In: Brain and Bannister's Clinical Neurology. 7th ed. India: Oxford Medical Publication; 1992: 283-294.
42. Gordon E, Kraiuhin C, Stanfield P, Meares R, Howson A. The prediction of normal P3 latency and the diagnosis of dementia. Neuropsychology 1986; 24: 823-830. (Pubitemid 17191299)
43. Pfefferbaum A, Wenegrat BG, Ford JM, Roth WT, Kopell BS. Clinical application of the P3 component of event-related potentials. II. Dementia, depression, schjzophrenia. Electroencephalogr Clin Neurophysiol 1984; 59(2): 104-124.
44. Molina JA, Jimenez-Jimenez FJ, Navarro JA. Cerebrospinal fluid nitrate levels with Parkinson's disease. Acta Neurol Scand 1996; 93: 123-126. (Pubitemid 26130678)
45. Salemme F, Diano S, Mahajan P. NO, a neuronal messenger. Its role in the hippocampus neuronal plasticity. Riv Biol 1996; 89(1): 87-107.